Literature DB >> 24102874

Antiretroviral medication: an emerging category of prescription drug misuse.

Glen P Davis1, Hilary L Surratt, Frances R Levin, Carlos Blanco.   

Abstract

BACKGROUND AND OBJECTIVES: Prescription drug abuse has been a focus of public health concern over the past two decades with many studies addressing patterns of narcotic analgesic abuse and diversion. Most research in this domain has centered on controlled substances with known abuse liability. However, the scientific literature has been virtually silent regarding other prescribed medications with previously undocumented addictive potential, such as antiretroviral (ARV) medications for treatment of human immunodeficiency virus.
METHODS: This article reviews the available evidence that suggests a growing problem of ARV diversion and abuse and explores the reasons for the misuse of these medications based on the theoretical neuropsychiatric effects of ARVs and the drug-drug interactions between ARVs and other drugs of abuse.
RESULTS: Review of media reports and qualitative studies suggest that ARV medications are emerging drugs of abuse. Claims about the psychoactive effects of ARV medications are supported by scientific case reports. CONCLUSIONS AND SCIENTIFIC SIGNIFICANCE: This article reviews the evidence to date of an emerging problem of diversion and misuse of ARV medications for recreational purposes. Implications of ARV misuse and diversion are discussed with suggestions for future research and intervention. © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24102874      PMCID: PMC3956727          DOI: 10.1111/j.1521-0391.2013.12107.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  32 in total

1.  Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs.

Authors:  K Kreth; K Kovar; M Schwab; U M Zanger
Journal:  Biochem Pharmacol       Date:  2000-06-15       Impact factor: 5.858

Review 2.  Neuropsychiatric reaction induced by clarithromycin in a patient on highly active antiretroviral therapy (HAART).

Authors:  K Prime; P French
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

3.  Drug points: Neuropsychiatric complications of nevirapine treatment.

Authors:  M E Jan Wise; K Mistry; S Reid
Journal:  BMJ       Date:  2002-04-13

Review 4.  Neurologic and psychiatric complications of antiretroviral agents.

Authors:  Glenn J Treisman; Adam I Kaplin
Journal:  AIDS       Date:  2002-06-14       Impact factor: 4.177

5.  Neuropsychiatric reaction induced by abacavir.

Authors:  Robert Colebunders; Robert Hilbrands; Ann De Roo; Jolanda Pelgrom
Journal:  Am J Med       Date:  2002-11       Impact factor: 4.965

6.  Cytochrome P450 2D6 genotype and methadone steady-state concentrations.

Authors:  C B Eap; F Broly; A Mino; R Hämmig; J J Déglon; C Uehlinger; D Meili; A F Chevalley; G Bertschy; D Zullino; M Kosel; M Preisig; P Baumann
Journal:  J Clin Psychopharmacol       Date:  2001-04       Impact factor: 3.153

7.  Cocaine metabolism in human fetal and adult liver microsomes is related to cytochrome P450 3A expression.

Authors:  M G Ladona; M L Gonzalez; A Rane; R M Peter; R de la Torre
Journal:  Life Sci       Date:  2000-12-15       Impact factor: 5.037

Review 8.  A brief history of antiretroviral therapy of HIV infection: success and challenges.

Authors:  Lucia Palmisano; Stefano Vella
Journal:  Ann Ist Super Sanita       Date:  2011       Impact factor: 1.663

Review 9.  Methadone, buprenorphine, and street drug interactions with antiretroviral medications.

Authors:  Valerie A Gruber; Elinore F McCance-Katz
Journal:  Curr HIV/AIDS Rep       Date:  2010-08       Impact factor: 5.071

10.  Antiretroviral medication diversion among HIV-positive substance abusers in South Florida.

Authors:  Hilary L Surratt; Steven P Kurtz; Theodore J Cicero; Catherine O'Grady; Maria A Levi-Minzi
Journal:  Am J Public Health       Date:  2013-04-18       Impact factor: 9.308

View more
  13 in total

1.  Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061.

Authors:  Iris Chen; Matthew B Connor; William Clarke; Mark A Marzinke; Vanessa Cummings; Autumn Breaud; Jessica M Fogel; Oliver Laeyendecker; Sheldon D Fields; Deborah Donnell; Sam Griffith; Hyman M Scott; Steven Shoptaw; Carlos del Rio; Manya Magnus; Sharon Mannheimer; Darrell P Wheeler; Kenneth H Mayer; Beryl A Koblin; Susan H Eshleman
Journal:  J Acquir Immune Defic Syndr       Date:  2015-08-01       Impact factor: 3.731

2.  Recreational ART use among individuals living with HIV/AIDS in South Africa: Examining longitudinal ART initiation and viral suppression.

Authors:  Jessica F Magidson; Hari S Iyer; Kristen S Regenauer; David J Grelotti; Janan J Dietrich; Ingrid Courtney; Gugu Tshabalala; Catherine Orrell; Glenda E Gray; David R Bangsberg; Ingrid T Katz
Journal:  Drug Alcohol Depend       Date:  2019-03-22       Impact factor: 4.492

Review 3.  A Systematic Review of Risk Factors and Consequences of Nyaope Usage: The Illicit Street Drug Containing HIV Antiretrovirals.

Authors:  Karan Varshney; Samuel D Browning; Sujit K Debnath; Pavan Shet; Darshan Shet
Journal:  AIDS Behav       Date:  2022-07-27

4.  Use of Antiretroviral Drug Testing to Assess the Accuracy of Self-reported Data from HIV-Infected People Who Inject Drugs.

Authors:  Jessica M Fogel; Yinfeng Zhang; Philip J Palumbo; Xu Guo; William Clarke; Autumn Breaud; Paul Richardson; Estelle Piwowar-Manning; Erica L Hamilton; Tran Viet Ha; Kostyantyn Dumchev; Zubairi Djoerban; Irving Hoffman; Brett Hanscom; William C Miller; Susan H Eshleman
Journal:  AIDS Behav       Date:  2019-08

5.  Recreational Use of HIV Antiretroviral Medication and Implications for HIV Pre-exposure Prophylaxis and Treatment.

Authors:  Caroline Kuo; Danielle Giovenco; Teresa DeAtley; Jackie Hoare; Kristen Underhill; Millicent Atujuna; Catherine Mathews; Dan J Stein; Larry K Brown; Don Operario
Journal:  AIDS Behav       Date:  2020-09

Review 6.  Substance use in older HIV-infected patients.

Authors:  E Jennifer Edelman; Jeanette M Tetrault; David A Fiellin
Journal:  Curr Opin HIV AIDS       Date:  2014-07       Impact factor: 4.283

Review 7.  An update on drug-drug interactions between antiretroviral therapies and drugs of abuse in HIV systems.

Authors:  Nuti Desai; Leah Burns; Yuqing Gong; Kaining Zhi; Asit Kumar; Nathan Summers; Santosh Kumar; Theodore J Cory
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-08-31       Impact factor: 4.481

8.  The Demand for Antiretroviral Drugs in the Illicit Marketplace: Implications for HIV Disease Management Among Vulnerable Populations.

Authors:  Kiyomi Tsuyuki; Hilary L Surratt; Maria A Levi-Minzi; Catherine L O'Grady; Steven P Kurtz
Journal:  AIDS Behav       Date:  2015-05

Review 9.  Polypharmacy in HIV: recent insights and future directions.

Authors:  E Jennifer Edelman; Christopher T Rentsch; Amy C Justice
Journal:  Curr Opin HIV AIDS       Date:  2020-03       Impact factor: 4.061

10.  Antiretroviral Drug Use in a Cohort of HIV-Uninfected Women in the United States: HIV Prevention Trials Network 064.

Authors:  Iris Chen; William Clarke; San-San Ou; Mark A Marzinke; Autumn Breaud; Lynda M Emel; Jing Wang; James P Hughes; Paul Richardson; Danielle F Haley; Jonathan Lucas; Anne Rompalo; Jessica E Justman; Sally L Hodder; Susan H Eshleman
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.